Huazhen Liang

Huazhen Liang

Auto-generated profile, based on publicly available information

Huazhen Liang

Department of Oncology, Maoming People's Hospital, Maoming, 525000, Guangdong, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YWYin Wang
Yin Wang
WZWeiwei Zeng
Weiwei Zeng
HLHuazhen Liang
Huazhen Liang
XWXixi Wu
Xixi Wu
HLHanyue Li
Hanyue Li
Lin MeiLin Mei
Lin Mei

6 December 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
HLHuazhen Liang
Huazhen Liang
YSYaling Sun
Yaling Sun
CLChaoming Li
Chaoming Li
HLHuaming Lin
Huaming Lin
QHQiwen Huang
Qiwen Huang
CLChangguo Li
Changguo Li
The exceptional biocompatibility and biosafety of natural proteins have made them a popular choice for tumor therapy in recent years, but their therapeutic effectiveness is severely constrained by factors including physiological instability, insufficient delivery, limited accumulation in tumor cells, etc. Here, a novel Mn-doped phycocyanin (Pc)/polydopamine (PDA) hierarchical nanostructure (MnPc@P) with excellent optical absorption, photothermal conversion, and photodynamic performances, is first designed and fabricated by a simply one-pot reaction, which not only successfully encapsulates natural protein Pc with intact activity in the nanostructure of MnPc@P but also gives them better biocompatibility. Upon laser irradiation, PDA-mediated hyperthermia and Pc-induced ROS elevation in tumor cells have been demonstrated, leading to drastic tumor cell death via combined PTT/PDT effect, greater than single PTT or PDT. In general, the expert fusion of Pc and PDA into a single nanomedicine opens fascinating perspectives in the delivery of natural proteins and tumor therapy.